← Leaderboards
Christopher B Shields
University Of Louisville
$1,429,512
Attributed
$1,429,512
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $258.9K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,429,512 · 6
By mechanism
P20$1,429,512 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Louisville
Same institution · by research overlap
- David S. K. Magnuson$6,325,664
- Michal Hetman$7,254,903
- Qilin Cao$4,039,605
- Stephen M Onifer$1,389,437
- Theo Hagg$10,681,523
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesResearch PersonnelFundingAxon GrowthComputer Retrieval Of Information On Scientific Projects DatabaseSourceUnited States National Institutes Of HealthAxon RegenerationInstitutionGrantSensoryBaseCombinatorialProgramsDorsalRecovery Of FunctionDigestionCellsConsultDorsal ColumnCenters Of Research ExcellenceNeuronsNeuritesRepaired
Grant awards (6)
COBRE: UL: CELL INSTRINSIC MECHANISMS REGULATING SENSORY AXON REGENERATION$242,742
P20 · FY2009 · RR · contact PI
COBRE: UL: CELL INSTRINSIC MECHANISMS REGULATING SENSORY AXON REGENERATION$219,017
P20 · FY2008 · RR · contact PI
COBRE: UL: STUDY THE ROLE OF LINGO01 IN VIVO SPINAL CORD REPAIR (SUB PKC)$234,410
P20 · FY2007 · RR · contact PI
COBRE: UL: PKC REGULATION OF REGENERATION ACROSS CSPG AFTER SCI$233,399
P20 · FY2006 · RR · contact PI
COBRE: UL: METHYLPREDNISOLONE AND SCI: A NEW APPROACH$258,925
P20 · FY2005 · RR
COBRE: UL: METHYLPREDNISOLONE AND SCI: A NEW APPROACH TO AN OLD THERAPY$241,019
P20 · FY2004 · RR